Brief: Peptidream Announces New Research And Collaboration Agreement With Lilly
27/12/2022 14:06
Dec 27 (Reuters) - PeptiDream Inc 4587.T :
* PEPTIDREAM ANNOUNCES NEW RESEARCH AND COLLABORATION
AGREEMENT
WITH LILLY FOR THE DISCOVERY OF NOVEL PEPTIDE DRUG CONJUGATES
* PEPTIDREAM INC - ELIGIBLE FOR PAYMENTS BASED ON
ACHIEVEMENT OF
SPECIFIED DEVELOPMENT, REGULATORY, MILESTONES POTENTIALLY
TOTALING UP TO $1.235 BILLION
* PEPTIDREAM INC - UNDER TERMS OF AGREEMENT, CO WILL RECEIVE
AN
UPFRONT PAYMENT FROM LILLY
Source text for Eikon: ID:nBw8pbw9va
Further company coverage: 4587.T
((reuters.briefs@thomsonreuters.com;))
Recent news on PeptiDream
See all newsTable: Peptidream 6-MTH group results (IFRS)
Brief: Peptidream Inc. - Initiation Of Phase 1 Clinical Trial By Novartis Marks Milestone For Peptidream
Brief: PeptiDream Announces First Dosing Of 64cu-Pd-29,875 In Gastric Cancer Patients
Table: Peptidream -Q1 group results (IFRS)
Brief: Peptidream Announces The Initiation Of Phase 1 Clinical Trial By Its Collaboration Partner